Cargando…

Lithium as an alternative option in thionamide-resistant Graves’ disease

Conventional treatments for Graves’ disease include thionamides, radioactive iodine therapy (RAI), and thyroidectomy. Occasionally, patients may develop resistance to thionamides and may require additional treatment. We present the case of an adolescent girl with thionamide-resistant Graves’ disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Ying Ki, Wong, Lap Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288288/ https://www.ncbi.nlm.nih.gov/pubmed/37362160 http://dx.doi.org/10.1297/cpe.2022-0070

Ejemplares similares

Lithium as an Alternative Option in Graves Thyrotoxicosis
por: Prakash, Ishita, et al.
Publicado: (2015)

The Thionamide Paradox: Thyrotoxicosis With Neutropenia as Initial Presentation of Grave’s Disease
por: Celis, Valentina, et al.
Publicado: (2021)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

THU655 Methimazole Desensitization As An Effective Alternative To Ablation Therapy In Patients With Graves’ Disease Experiencing Thionamide-induced Type IV Hypersensitivity Reactions
por: Arguinchona, Joseph, et al.
Publicado: (2023)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

Lithium Monotherapy in Graves Thyrotoxicosis
por: Larkworthy, James, et al.
Publicado: (2023)

Thionamide-Responsive Alopecia Areata in a 11 Year Girl
por: Sridhar, Subbiah, et al.
Publicado: (2023)

What is the Role of Race and Ethnicity in the Development Of Thionamide-Induced Neutropenia?
por: Ehrhart, Mark D, et al.
Publicado: (2018)

SAT460 Higher TSH Receptor Antibody At Diagnosis And Younger Age Predict Recurrence of Graves' Thyrotoxicosis After Thionamide Withdrawal At 10 Years
por: Wilson Gibb, Fraser, et al.
Publicado: (2023)

Association Between Thionamides and Acute Pancreatitis: A Case–Control Study
por: Guo, Jia-Yin, et al.
Publicado: (2020)

2141: What is the role of race and ethnicity in the development of thionamide-induced neutropenia?
por: Guthrie, Iric R., et al.
Publicado: (2018)

How to use thionamide anti-thyroid drug in the young– what’s new?
por: Cheetham, Tim
Publicado: (2021)

A review of treatment options for Graves’ disease: why total thyroidectomy is a viable option in selected patients
por: Mohan, Vinuta, et al.
Publicado: (2016)

Thyroid peroxidase forms thionamide-sensitive homodimers: relevance for immunomodulation of thyroid autoimmunity
por: McDonald, David O., et al.
Publicado: (2009)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
por: Wood, Claire L, et al.
Publicado: (2021)

Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial
por: Brammen, Lindsay, et al.
Publicado: (2018)

Prenatal management of fetal goiter alternating between hypothyroidism and hyperthyroidism in a mother with Graves’ disease
por: Didier‐Mathon, Hortense, et al.
Publicado: (2021)

Resistant Thyrotoxicosis in a Patient with Graves Disease: A Case Report
por: Saleem, Taimur, et al.
Publicado: (2011)

Graves’ disease coexisting with resistance to thyroid hormone: a rare case
por: Sun, Hongping, et al.
Publicado: (2017)

Graves’ disease coexisted with resistance to thyroid hormone: a case report
por: Akahori, Hiroshi, et al.
Publicado: (2021)

Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity
por: Song, Young Shin, et al.
Publicado: (2016)

Thymic hyperplasia in Graves' disease
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Thymic hyperplasia in Graves’ disease
por: Kotwal, Narendra, et al.
Publicado: (2013)

Pancytopenia related to Graves’ disease
por: Hegazi, Mohammed, et al.
Publicado: (2008)

An alternative option in the management of blunt splenic injury
por: Bodansky, David, et al.
Publicado: (2013)

Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?
por: Haftu, Hansa, et al.
Publicado: (2020)

A Case of Vogt-Koyanagi-Harada Disease in a Patient With Graves Disease
por: Seo, Je Hyun, et al.
Publicado: (2009)

Graves’ disease allied with multiple pheochromocytoma
por: Housni, Brahim, et al.
Publicado: (2013)

QT Prolongation due to Graves' Disease
por: Kulairi, Zain, et al.
Publicado: (2017)

Tozinameran: Graves' disease: case report
Publicado: (2021)

Myopathy Associated with Treatment of Graves’ Disease
por: Ji, Yoon-Kyung, et al.
Publicado: (2021)

Tozinameran: Graves' disease: case report
Publicado: (2022)

Tozinameran: Graves' disease : case report
Publicado: (2022)

Treatment of impacted canines with aligners: An alternative and viable option
por: Mampieri, Gianluca, et al.
Publicado: (2021)

Use of Lithium in Hyperthyroidism Secondary to Graves’ Disease: A Case Report
por: Sharma, Pranjali P.
Publicado: (2022)

A 3-year-old girl with Graves' disease with literature review
por: Ho, Yo Han, et al.
Publicado: (2014)

FRI523 A Case Of Acute Liver Failure Within 48 Hours Of Initiation Of High Dose Thionamides For Thyroid Storm
por: Noor, Laila, et al.
Publicado: (2023)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy
por: Pandit, Aditi, et al.
Publicado: (2013)

Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves’ Ophthalmopathy: a case report
por: Rau, Andrea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3oklvfaaquq6pduipa69suh1ir